Year: 2024
Type: dissertation
Abstract: Immunotherapies have had unprecedented success for multiple cancer types, but with variable response rates. Patients with epithelial ovarian carcinoma (EOC) often do not respond well to immune-based therapies. Unravelling the complex network of immune cells within the tumour microenvironment (TME) will provide additional mechanisms to enhance anti-tumour immunity and improve clinical response. This thesis examines the TME of EOC in two different approaches. First, we revealed unexpected differences in TME of clear cell ovarian carcinoma (CCC) compared to other histological subtypes of EOC including high-grade serous (HGSC) and endometrioid carcinoma (ENC). We found that CCC patients had intratumoural CD4+ T cells and CD8+ T cells with a naïve phenotype suggesting little evidence of immunosurveillance. Moreover, unlike HGSC tumours, CCC tumour did not have detectable levels of regulatory T cells (Tregs). Secondly, we uncovered a novel population of immunosuppressive innate lymphoid cells (ILCs) that were associated with poor prognosis and inhibitory TME with EOC. We also found that TGF-β/IL-15 polarized NK cells from peripheral blood into CD103+CD56+ ILCs that suppressed autologous CD4+ T cells in vitro. Overall, these findings shed light on the complex immune landscape of TME in ovarian cancer and may provide clues for novel therapeutic approaches for immunotherapy in these patients.
Source: TSpace (University of Toronto)
Author: Chung, Douglas Cho-Yan
Institution: University of Toronto
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: epithelial ovarian cancer, tumor microenvironment, ovarian clear cell carcinoma, high-grade serous ovarian cancer, endometrioid ovarian cancer, CD4+ T cells, CD8+ T cells, regulatory T cells, innate lymphoid cells, natural killer cells, immunosuppression, immunotherapy response, prognostic factors
Open Access status: green
OpenAlex ID: W7225766481
